Rockwell Medical, Inc. provided earnings guidance for the year 2024. For the year, the company expects Net (Product) Sales of $84.0 million to $88.0 million, 5% to 10% increase over $79.8 million in product sales for 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +3.12% | +1.23% | -12.70% |
04-17 | Rockwell Medical Continues to Expand Its Distribution Capabilities in Western United States | CI |
04-04 | Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.70% | 46.98M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical, Inc. Provides Earnings Guidance for the Year 2024